Journal of Liver Cancer

Search: J Liver Cancer Search

CLOSE

Review Article

September 30, 2019

Liver Transplantation in Mixed Hepatocellular Carcinoma and Cholangiocarcinoma

Jong Man Kim

J Korean Liver Cancer Stud. 2019;19(2):85-90.

Mixed hepatocellular carcinoma and cholangiocarcinoma (HCC-CC) are rare tumors, and the risk factors associated with them are not well understood yet. Moreover, the diagnosis of mixed HCC-CC can be complicated...

Review Article

September 30, 2019

Contrast-enhanced Ultrasonography: The Third Modality for Differentiation of Liver Mass

Min Kyu Kang, Moon Young Kim, Seong Hee Kang, et al.

J Korean Liver Cancer Stud. 2019;19(2):91-96.

Contrast-enhanced ultrasonography (CEUS) using microbubble ultrasonography contrast agent can show the vascular structure and unique contrast enhancement patterns of focal liver lesions, including hepatocellular carcinoma (HCC). CEUS shows three phases,...

Review Article

September 30, 2019

The Genomic Landscape and Its Clinical Implications in Hepatocellular Carcinoma

Sun Young Yim, Ju-Seog Lee

J Korean Liver Cancer Stud. 2019;19(2):97-107.

The pathogenesis of hepatocellular carcinoma (HCC) is a complex process. During the last decade, advances in genomic technologies enabled delineation of the genomic landscape of HCC, resulting in the identification...

Original Article

September 30, 2019

Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma

Hye Won Lee, Kyung Joo Cho, Soon Young Shin, et al.

J Korean Liver Cancer Stud. 2019;19(2):108-116.

Background/Aims: Programmed death receptor 1 (PD-1) is a promising new target for treatment of patients with hepatocellular carcinoma (HCC). A high expression level of programmed death-ligand 1 (PD-L1) is a...

Original Article

September 30, 2019

An Analysis for Survival Predictors for Patients with Hepatocellular Carcinoma Who Failed to Sorafenib Treatment in Pre-regorafenib Era

Chan Uk Lee, Young-Sun Lee, Ji Hoon Kim, et al.

J Korean Liver Cancer Stud. 2019;19(2):117-127.

Background/Aims: Sorafenib is the standard treatment for patients with advanced hepatocellular carcinoma (HCC). We aimed to investigate the prognosis predictors and the role of second-line cytotoxic systemic chemotherapy (CSC) in...

Original Article

September 30, 2019

Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Young Youn Cho, Young Hwan Choi, Su Jong Yu, et al.

J Korean Liver Cancer Stud. 2019;19(2):128-135.

Background/Aims: Tenofovir disoproxil fumarate (TDF) is potentially nephrotoxic in chronic hepatitis B patients. Hepatocellular carcinoma (HCC) patients treated using transarterial chemoembolization (TACE) are at an increased risk of renal injury....

Current Issue: Volume 19(2); Sep 2019

Liver Transplantation in Mixed Hepatocellular Carcinoma and Cholangiocarcinoma Jong Man Kim J Liver Cancer. 2019;19(2):85-90. Review Article September 30, 2019 Full text PubReader ePub PDF	Contrast-enhanced Ultrasonography: The Third Modality for Differentiation of Liver Mass Min Kyu Kang, Moon Young Kim, Seong Hee Kang, et al. J Liver Cancer. 2019;19(2):91-96. Review Article September 30, 2019 Full text PubReader ePub PDF
The Genomic Landscape and Its Clinical Implications in Hepatocellular Carcinoma Sun Young Yim, Ju-Seog Lee J Liver Cancer. 2019;19(2):97-107. Review Article September 30, 2019 Full text PubReader ePub PDF	Serum PD-1 Levels Change with Immunotherapy Response but Do Not Predict Prognosis in Patients with Hepatocellular Carcinoma Hye Won Lee, Kyung Joo Cho, Soon Young Shin, et al. J Liver Cancer. 2019;19(2):108-116. Original Article September 30, 2019 Full text PubReader ePub PDF Supplementary Material
An Analysis for Survival Predictors for Patients with Hepatocellular Carcinoma Who Failed to Sorafenib Treatment in Pre-regorafenib Era Chan Uk Lee, Young-Sun Lee, Ji Hoon Kim, et al. J Liver Cancer. 2019;19(2):117-127. Original Article September 30, 2019 Full text PubReader ePub PDF	Tenofovir and Entecavir Have Similar Renal Adverse Events on Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization Young Youn Cho, Young Hwan Choi, Su Jong Yu, et al. J Liver Cancer. 2019;19(2):128-135. Original Article September 30, 2019 Full text PubReader ePub PDF
Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular Carcinoma Jihye Kim, Gyu Sang Yoo, Dong Hyun Sinn, et al. J Liver Cancer. 2019;19(2):136-142. Case Report September 30, 2019 Full text PubReader ePub PDF	Malignant Hepatic Solitary Fibrous Tumor Hong Il Kim, Seok Kyung In, Hyung Suk Yi, et al. J Liver Cancer. 2019;19(2):143-148. Case Report September 30, 2019 Full text PubReader ePub PDF
Long-term Disease-free Survival after Trimodality Treatment of Recurrent Hepatocellular Carcinoma Involving the Inferior Vena Cava and Right Atrium Sunmin Park, Won Sup Yoon, Hyung Joon Yim, et al. J Liver Cancer. 2019;19(2):149-153. Case Report September 30, 2019 Full text PubReader ePub PDF Supplementary Material	Sorafenib-induced Pancreatic Pseudocyst in a Patient with Advanced Hepatocellular Carcinoma: a Rare Adverse Event Dae-ha Kim, Minkoo Kim, Hyung Joon Yim, et al. J Liver Cancer. 2019;19(2):154-158. Case Report September 30, 2019 Full text PubReader ePub PDF
Hepatocellular Carcinoma with Segmental Portal Vein Invasion Exhibiting a Complete Response after Transarterial Radioembolization Jun Sik Yoon, Su Jong Yu, Yun Bin Lee, et al. J Liver Cancer. 2019;19(2):159-164. Case Report September 30, 2019 Full text PubReader ePub PDF	Early Onset Polymorphic Post-transplant Lymphoproliferative Disease Mimicking a Solitary Necrotizing Abscess in a Graft Liver Pil Soo Sung, Jaejun Lee, Joon Lee, et al. J Liver Cancer. 2019;19(2):165-170. Case Report September 30, 2019 Full text PubReader ePub PDF

Editorial Office: 1527 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900 E-mail: liver@klcsg.or.kr